The pharmaceutical landscape is seeing a change with the emergence of GLP-1 transdermal systems . These innovative formulations offer a potential alternative to administering glucagon-like peptide-1 drugs https://adreaalda107783.blog2news.com/41456108/glp-1-patches-a-novel-way-to-control-the-condition